Profile avatar
sonkoning.bsky.social
Antimicrobial Stewardship Pharmacist with an interest in education and improving antibiotic use.
30 posts 1,277 followers 171 following
Regular Contributor
Conversation Starter
Posts 24 Comments 10

@elisemitri.bsky.social highlights the evidence and what’s next in antimicrobial allergies - lots happening in this space #antimicrobials2025 #AMSsky

submitted 6 days ago • 0 comments

Great speakers @michyong.bsky.social @cindyclau.bsky.social in the @ausantibiotics.bsky.social #antimicrobials2025 pharmacy symposium where Q&A sessions are turning into patient consults sessions 😉

submitted 6 days ago • 0 comments

Consider linezolid dose reduction in the following - elderly, renal impairment, hepatic dysfunction, concomitant clarithromycin @cindyclau.bsky.social #antimicrobials2025

submitted 6 days ago • 0 comments

“In wine there is truth, in beer there is strength, in water there is bacteria” 💯

submitted 6 days ago • 1 comment

NTM found in house dust 😱 Rachel Thompson on NTM epidemiology #antimicrobials2025 #ASA

submitted 6 days ago • 0 comments

What’s on the horizon for COVID for immunocompromised patients? Monoclonals, interferon nasal spray, T-cell therapy @michyong.bsky.social #antimicrobials2025 #ASA

submitted 7 days ago • 0 comments

Controversy - free range vs antibiotic free chickens? Which would you prefer?! 🫣🫣🫣#antimicrobials2025

submitted 7 days ago • 1 comment

Even more evidence that we should put our efforts on unrestricted antibiotics - high volume of use with low rates of appropriateness! @cazchen.bsky.social compares 2023 #NAPS and #NAUSP data #antimicrobials2025 #ASA

submitted 7 days ago • 0 comments

Another amazing whirlwind talk from @erinmccreary.bsky.social on the new antifungals featuring Nora 🐶 #antimicrobials2025 #ASA

submitted 7 days ago • 1 comment

This is another reason why topical antimicrobials should be #AMS targets 😳😳😳 @thefunguskidd.bsky.social presents on T.indotineae resistance

submitted 7 days ago • 0 comments

Another name change for Candida auris - “Candidozyma” belonging to the family “Metschnikowia” 😵‍💫😵‍💫😵‍💫 #antimicrobials2025 #ASA

submitted 7 days ago • 0 comments

Low MIC for zidebactam so cefepime-zidebactam is like giving two active agents rather than just adding an enzyme inhibitor #antimicrobials2025 #ASA

submitted 7 days ago • 0 comments

Privilege to be presenting in the same session with these superstar pharmacists 🤩🤩🤩 #antimicrobials2025

submitted 8 days ago • 0 comments

IVOS not only has great benefits for our patients but saves nursing time 👌🏻👌🏻👌🏻 Great presentation from @nikhil-singh.bsky.social #antimicrobials2025 @ausantibiotics.bsky.social

submitted 8 days ago • 0 comments

Sadly I feel like this is many of our AMS rounds 🤦🏻‍♀️🤦🏻‍♀️🤦🏻‍♀️ #AMSsky

submitted 88 days ago • 0 comments

Long term suppression antibiotics often done - but is there sufficient evidence to support this?? @jillianlau.bsky.social nice to see SOLLA being highlighted for #WAAW2024 #AMSsky

submitted 98 days ago • 0 comments

Entertaining and informative session from @trubianojason.bsky.social on disseminating research #WAAW #AMSsky

submitted 98 days ago • 1 comment

🔥BALANCE RCT🔥 74 hospitals in 7 countries 3,608 patients A 7-day course of antibiotics for hospitalized patients with bloodstream infections was non inferior to 14d within a 4% prespecified margin for mortality at 90 days #idsky www.nejm.org/doi/full/10....

submitted 99 days ago • 10 comments

This is hands down still my fav #WAAW activity!! @brxad.bsky.social is a genius!!

submitted 101 days ago • 1 comment

To kick off World #AMR Awareness Week this year why don't you try out our little Emoji Quiz! 🤔 👉🏼 www.superbugs.online/emojis 🐅🚴🏼‍♂️ #WAAW #WAAW2024

submitted 102 days ago • 0 comments

Lessons from practice for immunocompromised hosts by Dr Ai Li Yeo and A/Prof Claire Dendle #ForbesWeek #IDSky 1. There can be more than two pathologies in immunocompromised patients

submitted 104 days ago • 1 comment

The ABCs after organ transplantation! Great oration from @kottonnelson.bsky.social #ForbesWeek #IDSky #TIDSky

submitted 105 days ago • 0 comments

Interesting! SubQ meropenem. “Subcutaneous meropenem appears to be well tolerated and has a favourable pharmacokinetic profile. Either 1.5 g twice daily or 3 g as a 24 h subcutaneous infusion could be considered for future evaluation.” academic.oup.com/jac/advance-...

submitted 108 days ago • 8 comments

IDSky continues to grow rapidly We are now >300 users, which means we are on a third Starter Pack IDSky Starter Pack 1 go.bsky.app/LnAQjdq IDSky Starter Pack 2 go.bsky.app/JNfSvQT ID Starter Pack 3 go.bsky.app/FeogT7o Check back on the most recent one often as it is updated frequently

submitted 110 days ago • 36 comments